Identification | Back Directory | [Name]
N-(4-bromophenyl)-2-(6-ethylthieno[2,3-d]pyrimidin-4-yl)sulfanylacetamide | [CAS]
421578-44-1 | [Synonyms]
WAY-270966 N-(4-bromophenyl)-2-(6-ethylthieno[2,3-d]pyrimidin-4-yl)sulfanylacetamide Acetamide, N-(4-bromophenyl)-2-[(6-ethylthieno[2,3-d]pyrimidin-4-yl)thio]- | [Molecular Formula]
C16H14BrN3OS2 | [MOL File]
421578-44-1.mol | [Molecular Weight]
408.34 |
Hazard Information | Back Directory | [Uses]
p38 MAPK-IN-6 (compound c47) is a p38 MAPK inhibitor. p38 MAPK-IN-6 shows 14% inhibition at 10 μM[1]. | [References]
[1] Cheeseright TJ, et al.Novel lead structures for p38 MAP kinase via FieldScreen virtual screening. J Med Chem. 2009 Jul 23;52(14):4200-9. DOI:10.1021/jm801399r |
|
Company Name: |
PHARMEKS Ltd.
|
Tel: |
+7 (495) 702-9648 |
Website: |
www.pharmeks.com |
|